Ownership history in ORBIMED ADVISORS LLC · 7 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in ADC THERAPEUTICS SA (ADCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 5,822,854 | -84,497 | -1.4% | 0.42% | $20.6M | $3.53 |
| 2025 Q3 | UNCHANGED | 5,907,351 | — | 0% | 0.56% | $23.6M | $4.00 |
| 2025 Q2 | REDUCED | 5,907,351 | -61,100 | -1.0% | 0.40% | $15.8M | $2.68 |
| 2025 Q1 | UNCHANGED | 5,968,451 | — | 0% | 0.20% | $8.4M | $1.41 |
| 2024 Q4 | ADDED | 5,968,451 | +1,434,650 | +31.6% | 0.24% | $11.9M | $1.99 |
| 2024 Q3 | ADDED | 4,533,801 | +216,977 | +5.0% | 0.26% | $14.3M | $3.15 |
| 2024 Q2 | INITIATED | 4,316,824 | — | — | 0.27% | $13.6M | — |
As of 2025 Q4 — sorted by position size